Blinatumomab
Formulations: - Parenteral > General injections > IV: 35 µg in vial; 38.5 µg in vial Indications: - B lymphoblastic leukaemia or lymphoma, not elsewhere classified Source: EML workbook import
MOQ: 1
Price on request
Catalogue
Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
All Products (Showing 288 out of 662)
Cemiplimab
Formulations: - Parenteral > General injections > IV: 50 mg per mL in 7 mL vial concentrate for solution for infusion Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
MOQ: 1
Price on request
Filgrastim
Formulations: - Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial Indications: - Acquired neutropaenia Source: EML workbook import
MOQ: 1
Price on request
Lenalidomide
Formulations: - Oral > Solid: 25 mg Indications: - Plasma cell myeloma Source: EML workbook import
MOQ: 1
Price on request
Nivolumab
Formulations: - Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion; 10 mg per mL in 24 mL vial concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 24 mL vial concentrate solution for infusion; 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion Indications: - Other specified malignant neoplasms of bronchus or lung - Melanoma of skin - Renal cell carcinoma of kidney, except renal pelvis - Squamous cell carcinoma of oesophagus - Adenocarcinoma of oesophagogastric junction - Adenocarcinoma of stomach Source: EML workbook import
MOQ: 1
Price on request
Pegfilgrastim
Formulations: - Parenteral > General injections > SC: 6 mg per 0.6 mL in pre-filled syringe Indications: - Acquired neutropaenia Source: EML workbook import
MOQ: 1
Price on request
Pembrolizumab
Formulations: - Parenteral > General injections > IV: 25 mg per mL in 4 mL vial Parenteral > General injections > IV: 25 mg per mL in 4 mL vial powder for injection Parenteral > General injections > IV: 25 mg per mL in 4 mL vial concentrate for solution for infusion Indications: - Melanoma of skin Source: EML workbook import
MOQ: 1
Price on request
Thalidomide
Formulations: - Oral > Solid: 50 mg Indications: - Plasma cell myeloma Source: EML workbook import
MOQ: 1
Price on request
Ciclosporin
Formulations: - Parenteral > General injections > IV: 50 mg per mL in 1 mL ampoule concentrate for injection Oral > Liquid: 100 mg per mL Oral > Solid > capsule: 25 mg Indications: - Failure or rejection of transplanted organs or tissues Source: EML workbook import
MOQ: 1
Price on request
Golimumab
Indications: - Axial spondyloarthritis - Crohn disease site - Rheumatoid arthritis - Juvenile idiopathic arthritis Source: EML workbook import
MOQ: 1
Price on request
Tacrolimus
Formulations: - Parenteral > General injections > IV: 5 mg per mL in 1 mL vial Oral > Liquid: 0.2 mg granules for oral suspension; 1 mg granules for oral suspension Oral > Solid: 0.5 mg (immediate-release); 0.75 mg (immediate-release); 1 mg (immediate-release); 2 mg (immediate-release); 5 mg (immediate-release) Indications: - Failure or rejection of transplanted organs or tissues Source: EML workbook import
MOQ: 1
Price on request
Etonogestrel-Releasing Implant
Formulations: - Implant > Subdermal: 68 mg single rod Indications: - Contact with health services for insertion of contraceptive device Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.